TrialNCT03368118Phase 2Completed
Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis
Study sponsor: Abivax S.A. · ABVX
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2022-07-12Actual
Enrollment · participants22Actual
Source updated2025-05-29Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.